Inflammation precedes the development of human malignant mesotheliomas in a SCID mouse xenograft model
about
New insights into understanding the mechanisms, pathogenesis, and management of malignant mesotheliomasCancer microenvironment, inflammation and cancer stem cells: A hypothesis for a paradigm change and new targets in cancer controlThe NLRP3 inflammasome in pathogenic particle and fibre-associated lung inflammation and diseasesBioanalytical techniques for detecting biomarkers of response to human asbestos exposureAsbestos and erionite prime and activate the NLRP3 inflammasome that stimulates autocrine cytokine release in human mesothelial cellsA multifunctional mesothelin antibody-tagged microparticle targets human mesotheliomasMolecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesotheliomaCurcumin: a double hit on malignant mesotheliomaTumour suppressor Fus1 provides a molecular link between inflammatory response and mitochondrial homeostasisInflammasome Modulation by Chemotherapeutics in Malignant MesotheliomaFTY720 inhibits mesothelioma growth in vitro and in a syngeneic mouse modelHMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma.Mesothelioma: recent highlights.The Cappadocia mesothelioma epidemic: its influence in Turkey and abroad.Increased levels of C-C chemokine RANTES in asbestos exposed workers and in malignant mesothelioma patients from an hyperendemic area.CREB-induced inflammation is important for malignant mesothelioma growth.New roads open up for implementing immunotherapy in mesothelioma.Microspheres targeted with a mesothelin antibody and loaded with doxorubicin reduce tumor volume of human mesotheliomas in xenograftsThe role of interleukin-6 in malignant mesotheliomaAre neutrophil/lymphocyte ratio and platelet/lymphocyte ratio reliable parameters as prognostic indicators in malignant mesothelioma?Differential Susceptibility of Human Pleural and Peritoneal Mesothelial Cells to Asbestos Exposure.Flaxseed lignans enriched in secoisolariciresinol diglucoside prevent acute asbestos-induced peritoneal inflammation in mice.The proliferative effects of asbestos-exposed peripheral blood mononuclear cells on mesothelial cells.Investigating palygorskite's role in the development of mesothelioma in southern Nevada: Insights into fiber-induced carcinogenicityInterleukin-8 (CXCL8) in tumor associated non-vascular extracellular fluids: its diagnostic and prognostic values. A review.Inhibition of the spindle assembly checkpoint kinase Mps-1 as a novel therapeutic strategy in malignant mesothelioma.Asbestos-Induced Mesothelial to Fibroblastic Transition Is Modulated by the Inflammasome.Safety and toxicity of nanomaterials for ocular drug delivery applications.Receptor role of the annexin A2 in the mesothelial endocytosis of crocidolite fibers.Antitumor effects of TRAIL-expressing mesenchymal stromal cells in a mouse xenograft model of human mesothelioma.Malignant Peritoneal Mesothelioma: Characterization of the Inflammatory Response in the Tumor Microenvironment.Extracellular signal-regulated kinase 5: a potential therapeutic target for malignant mesotheliomas.SASP mediates chemoresistance and tumor-initiating-activity of mesothelioma cells.The role of iron in Libby amphibole-induced acute lung injury and inflammation.Prognostic value of the lymphocyte-to-monocyte ratio and other inflammatory markers in malignant pleural mesothelioma.The Synthetic Lignan Secoisolariciresinol Diglucoside Prevents Asbestos-Induced NLRP3 Inflammasome Activation in Murine Macrophages.The value of inflammatory parameters in the prognosis of malignant mesothelioma.HSP90 inhibition alters the chemotherapy-driven rearrangement of the oncogenic secretome.Characterization of pulmonary responses in mice to asbestos/asbestiform fibers using gene expression profiles.
P2860
Q26859274-F37AF77E-7F3B-4A96-9552-9C4CA117DF9FQ26860058-999D713F-8431-47F0-BBDF-BE6D0342C085Q28080249-38022572-5892-460F-9E7C-7C48F44D2FE6Q28082088-EB24C28D-DC00-4BE8-BA98-1B2F2E3D6C3DQ28387699-B97D923F-9611-45D3-99AD-75534E08C863Q28392105-B72203C0-296D-45CA-AC07-29C69A7CDD3EQ28397153-722A9FF5-D4B6-4D1C-A75B-00FA52D5961DQ28397518-21B4519A-D3A0-4625-9BA3-0D3D76745885Q28507927-EC97E213-CF63-4437-B6FB-17394C4C1710Q28551670-BAB38298-73A9-4B3A-AAB6-66D9A8991FACQ29248124-244CB5A0-5841-4935-B543-33CC4C349026Q33618428-ACF0113D-D20E-4A5A-B917-32D755C698B0Q33871606-367B9F3F-0CAA-400E-B743-8C5A448AA61EQ33871638-1D90F919-AEFE-48E9-8C9E-6F951F70EF4CQ34097257-1E84F6DB-684E-4688-9FFE-BD495F467FC4Q34302855-233058B4-3E4E-4E7A-84C1-4A01F7727B76Q34331993-BAB7FA17-74C9-4163-8C48-162862BA6807Q34984956-082824E5-9C67-4ED8-BF2C-339796069668Q35200628-21B17B67-5A9E-419B-A6AC-AC481F8719E1Q36027639-C2357407-3309-470C-A4BA-49C7AE0B050AQ36423603-819269FF-2ACC-4773-B92C-AAD2B6D6066AQ36557014-035F4D00-E6F1-4FC2-8E29-CC44E9ED487EQ36825187-7DA35A61-EC5C-47A7-98B5-5CF0AF165B98Q37335386-5B7170AB-A9E3-4924-9214-58C65C8F7C69Q38011647-1F64B222-9BB6-4318-8661-802D21BCE996Q38429562-DB21B0E0-A698-476E-B193-16107CCB8030Q38722819-355173A6-245B-4299-B086-10F20F75D886Q38793489-66BCC0FF-8D89-44DE-820F-821FD40D97EDQ38881972-68D99658-8285-4DFF-961F-E61A607569EEQ38927008-0C3BEC42-F407-4EA1-BEED-D3257B3DAE78Q38945362-5BE26548-2389-4FF0-A674-8AD93314CA4BQ39187582-3461FDC1-5BFF-41B4-B2D8-A918098A3ACDQ39454272-02B7B6DB-2116-493A-BC85-F612739552B5Q39538064-7A4D8362-9284-46D6-9CD0-A5CA0919C76EQ42000248-A8C1FDF6-6363-49B6-844E-5A8C4243EE95Q42725585-B8E1EF6D-6341-4ED9-B00A-E9D9B02B0495Q43595658-7FF7F9E0-890E-474A-8306-06322A3824BDQ48292976-F28FCA60-09DE-4F65-9CBE-5FC7B68B3F14Q49570420-58898030-F082-480C-AAB6-B0F307E9B085
P2860
Inflammation precedes the development of human malignant mesotheliomas in a SCID mouse xenograft model
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Inflammation precedes the deve ...... n a SCID mouse xenograft model
@ast
Inflammation precedes the deve ...... n a SCID mouse xenograft model
@en
Inflammation precedes the deve ...... n a SCID mouse xenograft model
@nl
type
label
Inflammation precedes the deve ...... n a SCID mouse xenograft model
@ast
Inflammation precedes the deve ...... n a SCID mouse xenograft model
@en
Inflammation precedes the deve ...... n a SCID mouse xenograft model
@nl
prefLabel
Inflammation precedes the deve ...... n a SCID mouse xenograft model
@ast
Inflammation precedes the deve ...... n a SCID mouse xenograft model
@en
Inflammation precedes the deve ...... n a SCID mouse xenograft model
@nl
P2093
P2860
P1476
Inflammation precedes the deve ...... n a SCID mouse xenograft model
@en
P2093
Arti Shukla
Brooke T Mossman
Chad Steele
Jedd M Hillegass
Joseph R Testa
Kelly J Butnor
Maximilian B MacPherson
Michele Carbone
Sherrill A Lathrop
Stacie L Beuschel
P2860
P356
10.1111/J.1749-6632.2010.05554.X
P407
P577
2010-08-01T00:00:00Z